TIMOTHY WILLIAM TURNER, the Chief Executive Officer of $RYAN, sold 129,570 shares of the company on 12-12-2025 for an estimated $6,946,247. We received data on the trade from a recent SEC filing. This was a sale of approximately 91.2% of their shares of this class of stock. Following this trade, they now own 12,553 shares of this class of $RYAN stock.
$RYAN Insider Trading Activity
$RYAN insiders have traded $RYAN stock on the open market 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $RYAN stock by insiders over the last 6 months:
- CORP ONEX sold 4,145,621 shares for an estimated $225,936,344
- PATRICK G RYAN (Executive Chairman) purchased 276,634 shares for an estimated $14,340,263
- TIMOTHY WILLIAM TURNER (Chief Executive Officer) sold 129,570 shares for an estimated $6,946,247
- PATRICK G JR RYAN purchased 100 shares for an estimated $5,554
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RYAN Hedge Fund Activity
We have seen 209 institutional investors add shares of $RYAN stock to their portfolio, and 207 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,339,680 shares (+125.9%) to their portfolio in Q3 2025, for an estimated $131,864,364
- INDEPENDENT FRANCHISE PARTNERS LLP added 1,699,753 shares (+inf%) to their portfolio in Q3 2025, for an estimated $95,798,079
- INVESCO LTD. removed 1,658,441 shares (-88.9%) from their portfolio in Q3 2025, for an estimated $93,469,734
- CHAMPLAIN INVESTMENT PARTNERS, LLC added 1,332,773 shares (+76.9%) to their portfolio in Q3 2025, for an estimated $75,115,086
- AMERICAN CENTURY COMPANIES INC removed 1,247,862 shares (-99.5%) from their portfolio in Q3 2025, for an estimated $70,329,502
- BARCLAYS PLC removed 1,195,460 shares (-89.8%) from their portfolio in Q3 2025, for an estimated $67,376,125
- ALLIANCEBERNSTEIN L.P. removed 931,517 shares (-84.2%) from their portfolio in Q3 2025, for an estimated $52,500,298
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RYAN Revenue
$RYAN had revenues of $754.6M in Q3 2025. This is an increase of 24.79% from the same period in the prior year.
You can track RYAN financials on Quiver Quantitative's RYAN stock page.
$RYAN Analyst Ratings
Wall Street analysts have issued reports on $RYAN in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 11/26/2025
- Barclays issued a "Overweight" rating on 11/20/2025
- Morgan Stanley issued a "Overweight" rating on 11/17/2025
- BMO Capital issued a "Outperform" rating on 11/03/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 11/03/2025
- Goldman Sachs issued a "Buy" rating on 11/03/2025
- Wells Fargo issued a "Overweight" rating on 10/08/2025
To track analyst ratings and price targets for $RYAN, check out Quiver Quantitative's $RYAN forecast page.
$RYAN Price Targets
Multiple analysts have issued price targets for $RYAN recently. We have seen 12 analysts offer price targets for $RYAN in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Andrew Andersen from Jefferies set a target price of $64.0 on 12/01/2025
- Andrew Kilgerman from TD Cowen set a target price of $76.0 on 11/26/2025
- Paul Newsome from Piper Sandler set a target price of $60.0 on 11/20/2025
- Alex Scott from Barclays set a target price of $65.0 on 11/20/2025
- Bob Huang from Morgan Stanley set a target price of $67.0 on 11/17/2025
- Michael Zaremski from BMO Capital set a target price of $66.0 on 11/03/2025
- Robert Cox from Goldman Sachs set a target price of $63.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
